Natural Biocon (India) Ltd

Key board actions

• Un-Audited standalone financial results for the quarter ended June 30, 2026 approved with Limited Review Report.
• Appointment of Nirav S Shah & Co as statutory auditors, effective 1 August 2026.
• Resignation of Mayur Shah & Associates as statutory auditors, effective 31 July 2026.
• Company has a single reportable segment; segment reporting not applicable.
• Board reviewed other businesses of the company.
• Results prepared per IND AS and in compliance with MCA notifications.

Meeting Details

• Date: 14 August 2026 (Friday).
• Time: not disclosed.
• Location: Registered Office of the Company.

Key Agenda Items

• Consider unaudited financial results for the quarter ended June 30, 2026 with Limited Review Report.
• Appoint M/s Nirav S Shah & Co as Statutory Auditors.
• Note resignation of M/s Mayur Shah & Associates as Statutory Auditors.

Resignations

• Accepted the resignation of Mrs. Tapasya Sheth from the Directorship, effective 14 July 2026.
• Accepted the resignation of Mrs. Minaben Shah from the Directorship, effective 14 July 2026.

Dematerialisation status

• Dematerialisation requests were processed and confirmed to the depositories (accepted or rejected).
• Dematerialised securities have been listed on the stock exchanges where existing securities are listed.
• Physical certificates for dematerialisation were mutilated and cancelled; depository's name substituted as registered owner within 15 days.

Independent Directors Meeting Outcome

• Reviewed performance of non-independent directors and entire board
• Reviewed chairperson's performance with input from executive and non-executive directors
• Assessed quality, quantity, and timeliness of management-board information flow

Meeting Details ️

• Independent Directors Meeting scheduled for 20th March 2026 at the company's registered office.

Key Agenda Items

• Review performance of Non-Independent Directors and the Board as a whole.
• Assess Chairperson's performance.
• Evaluate quantity, quality, and timeliness of information flow.

🗓️ Meeting Details

• Board meeting scheduled for 13 February 2026 at the company's registered office.

📊 Financial Performance

• Approval of unaudited financial results for Q3 ended 31 December 2025.
• Consideration of Auditor's Limited Review Report for Q3 ended 31 December 2025.